Charles River Laboratories (CRL) Q3 Earnings and Revenues Beat Estimates
Portfolio Pulse from
Charles River Laboratories (CRL) reported Q3 earnings of $2.59 per share, surpassing the Zacks Consensus Estimate of $2.43. This is a decrease from last year's $2.72 per share.
November 06, 2024 | 2:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Charles River Laboratories reported Q3 earnings of $2.59 per share, exceeding expectations but lower than last year's $2.72. This earnings beat may positively influence short-term stock prices.
CRL's earnings per share exceeded analyst expectations, which is typically viewed positively by investors and can lead to a short-term increase in stock price. However, the earnings are lower than the previous year, which may temper the positive impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100